GDF15 mediates the effects of metformin on body weight and energy balance
Metformin, the world's most prescribed anti-diabetic drug, is also effective in preventing type
2 diabetes in people at high risk,. More than 60% of this effect is attributable to the ability of …
2 diabetes in people at high risk,. More than 60% of this effect is attributable to the ability of …
Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss
EA Day, RJ Ford, BK Smith… - Nature …, 2019 - nature.com
Metformin is the most commonly prescribed medication for type 2 diabetes, owing to its
glucose-lowering effects, which are mediated through the suppression of hepatic glucose …
glucose-lowering effects, which are mediated through the suppression of hepatic glucose …
[PDF][PDF] The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance
Metformin is a blood-glucose-lowering medication with physiological effects that extend
beyond its anti-diabetic indication. Recently, it was reported that metformin lowers body …
beyond its anti-diabetic indication. Recently, it was reported that metformin lowers body …
GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
SE Mullican, X Lin-Schmidt, CN Chin, JA Chavez… - Nature medicine, 2017 - nature.com
Abstract Growth differentiation factor 15 (GDF15), a distant member of the transforming
growth factor (TGF)-β family, is a secreted protein that circulates as a 25-kDa dimer. In …
growth factor (TGF)-β family, is a secreted protein that circulates as a 25-kDa dimer. In …
The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL
PJ Emmerson, F Wang, Y Du, Q Liu, RT Pickard… - Nature medicine, 2017 - nature.com
Abstract Growth/differentiation factor 15 (GDF15), also known as MIC-1, is a distant member
of the transforming growth factor-β (TGF-β) superfamily and has been implicated in various …
of the transforming growth factor-β (TGF-β) superfamily and has been implicated in various …
GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand
Abstract Growth differentiation factor 15 (GDF15; also known as MIC-1) is a divergent
member of the TGF-β superfamily and is associated with body-weight regulation in humans …
member of the TGF-β superfamily and is associated with body-weight regulation in humans …
[HTML][HTML] GDF15 promotes weight loss by enhancing energy expenditure in muscle
D Wang, LK Townsend, GJ DesOrmeaux, SM Frangos… - Nature, 2023 - nature.com
Caloric restriction that promotes weight loss is an effective strategy for treating non-alcoholic
fatty liver disease and improving insulin sensitivity in people with type 2 diabetes. Despite its …
fatty liver disease and improving insulin sensitivity in people with type 2 diabetes. Despite its …
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
Abstract Growth differentiation factor 15 (GDF15) is a member of the TGFβ superfamily
whose expression is increased in response to cellular stress and disease as well as by …
whose expression is increased in response to cellular stress and disease as well as by …
GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanism
KA Sjøberg, CM Sigvardsen, A Alvarado-Diaz… - Cell Metabolism, 2023 - cell.com
Summary Growth differentiation factor 15 (GDF15) induces weight loss and increases insulin
action in obese rodents. Whether and how GDF15 improves insulin action without weight …
action in obese rodents. Whether and how GDF15 improves insulin action without weight …
[HTML][HTML] Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise
Growing evidence supports that pharmacological application of growth differentiation factor
15 (GDF15) suppresses appetite but also promotes sickness-like behaviors in rodents via …
15 (GDF15) suppresses appetite but also promotes sickness-like behaviors in rodents via …